Please find enclosed proceedings/outcome of 37th Annual General Meeting of the Company held on August 6, 2026.

GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2026-27 August 6, 2026 The Department of Corporate Services National Stock Exchange of India Limited BSE Limited, Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Dalal Street Mumbai - 400 051 Mumbai – 400001 Scrip Symbol: GPTHEALTH Scrip Code: 544131 ISIN: INE486R01017 Dear Sir/Madam Subject: Submission of Proceedings of 37th Annual General Meeting of the Company: In continuation to our earlier letter July 9, 2026, we wish to inform you that the 37th Annual General Meeting (‘AGM/Meeting’) of the Company was held on Thursday, August 6, 2026 at 3.00 P.M. (IST) through Video Conferencing (‘VC’)/Other Audio Visual Means (‘OAVM’) in compliance with the latest General Circular No. 03/2025 dated September 22, 2025 issued by Ministry of Corporate Affairs (“MCA”) read together with other previous circulars issued by MCA in this regard (collectively referred to as “MCA Circulars’) and the applicable provisions of the Companies Act, 2013 read with rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and the business(es) mentioned in the Notice dated May 18, 2026 for convening the Meeting (‘Notice’), were duly transacted. In this regard, please find enclosed the summary of proceedings as required under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as Annexure-A. The meeting commenced at 03:00 P.M.(IST) and concluded at 04:26 P.M.(IST) (including the time allowed for e-voting at the AGM). Kindly take the aforesaid information on record and oblige. Thanking You, Yours sincerely, For GPT Healthcare Limited Ankur Sharma Company Secretary and Compliance Officer M.No A31833 Enclosed: A/a 1.National Securities Depository Limited, Trade World, A Wing, 4th Floor, Kamala Mills Compound, Senpati Bapat Marg, Lower Parel, Mumbai – 400 013 2. Central Depository Services (India) Ltd, Marathon Futurex, A Wing, 25th Floor, Mafatlal Mills Compound, N M Joshi Marg, Lower Parel, Mumbai – 400 013 Annexure-A The 37th Annual General Meeting (‘AGM/Meeting’) of the Company was held on Thursday, August 6, 2026 at 3.00 P.M. (IST) through Video Conferencing (‘VC’)/Other Audio Visual Means (‘OAVM’) in compliance with the latest General Circular No. 03/2025 dated September 22, 2025 issued by Ministry of Corporate Affairs (“MCA”) read together with other previous circulars issued by MCA in this regard (collectively referred to as “MCA Circulars’) and the applicable provisions of the Companies Act, 2013 read with rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and the business(es) mentioned in the Notice dated May 18, 2026 for convening the Meeting (“Notice”), were duly transacted. Before commencing the proceedings, Mr. Ankur Sharma, Company Secretary and Compliance Officer of the Company, extended a warm welcome to all the members attending the meeting through VC/OAVM and thereafter, introduced the Board of Directors and Key Managerial Personnel of the Company. The following Directors and Key Managerial Personnel were present through Video Conference from their respective locations: SNO Name of the Directors/KMPs Designation 1 Dr. Om Tantia Chairman and Managing Director 2 Dr. Aruna Tantia Non-Executive Non-Independent Director 3 Mr. Anurag Tantia Executive Director 4 Dr. Ghanshyam Goyal Non-Executive Non-Independent Director 5 Mr. Kashi Prasad Khandelwal Independent Director and Chairman of Nomination and Remuneration Committee 6 Mr. Deepak Pramanik Independent Director and Chairman of Audit Committee 7 Mr. Hari Modi Independent Director and Chairman of Stakeholders Relationship Committee 8 Dr. Tapti Sen Independent Director 9 Mrs. Kriti Tantia Chief Financial Officer 10 Mr. Ankur Sharma Company Secretary and Compliance Officer Further, the representatives of Statutory Auditors, Secretarial Auditors and the Scrutinizer for the meeting were also present at the meeting. Dr. Om Tantia, Chairman and Managing Director of the Company took the chair for the 37th AGM of the Company as per the provision of Article of the Articles of Association of the Company and greeted the members. As per the records of attendance, 66 (Sixty Six) members holding 65.60% shares of the Company attended the Meeting. Mr. Ankur Sharma confirmed to the Chairman that the requisite quorum is present to proceed with the meeting. As the requisite quorum was present, the Chairman then called the Meeting to order. Mr. Ankur Sharma further briefed the members on the general instructions relating to their participation at the Meeting and also informed that the Company had taken all feasible efforts for conducting this AGM in a smooth manner to enable participation and voting through electronic mode. It was also informed that as stated in the notes set out in the Notice, the statutory registers required under the Act were available electronically for inspection by the members during the AGM by sending request(s) as per the guidelines stated in the Notice. The Company Secretary also informed the Members that the soft copies of the the Notice along with the Annual Audited Financial Statements with Directors’ and Auditors’ Report for the year ended March 31, 2026 were sent by email to all those Members, whose email addresses are registered with the Company/RTA/DP in accordance with the Circulars issued by the MCA and SEBI and a letter providing the web-link, including the exact path, where Annual Report for the financial year 2025-26 is available, was also sent to those members whose e-mail address is not registered with Company/RTA/DP. Also, a public Notice was published in this regard in News Papers as required under law. With the consent of the members present at the Meeting, the Notice along with the Annual Audited Financial Statements with Directors’ and Auditors’ Report for the year ended March 31, 2026 as sent to the members and available on the Company’s website, were taken as read. It was confirmed that the Auditors’ Report does not contain any qualifications/modified opinion or adverse remarks. Thereafter, Dr. Om Tantia, Chairman and Managing Director, delivered his speech and apprised the Members about the Company's financial performance, key achievements, the current and future business prospects of the Company and initiatives undertaken by the Company amongst other notable highlights. Post conclusion of the Chairman’s speech, the business items as stated in the Notice were transacted one by one. In terms of the Notice, the following items of business were transacted at the Meeting: Sl. Item of Businesses Type of No Resolution ORDINARY BUSINESS 1. To receive, consider and adopt the audited financial statements of Ordinary the Company as at and for the financial year ended March 31, 2026 Resolution together with Reports of Board of Directors and Auditors thereon 2. To confirm the payment of Interim Dividend of ₹1 (10%) per Equity Ordinary Share of ₹10 each, and to declare Final Dividend of ₹1.50 (15%) per Resolution Equity Share of ₹10 each for the financial year 2025-26 3. To appoint a Director in place of Dr. Aruna Tantia (DIN: 00001347), Ordinary who retires by rotation at this Annual General Meeting and being Resolution eligible, offers herself for re-appointment SPECIAL BUSINESS 4. To ratify the Remuneration of Cost Auditors for the FY 2026-27 Ordinary Resolution 5 To consider approval for increase in remuneration of Dr. Mridul Ordinary Tantia, “Vice President” and a relative of Director holding office or Re [Showing first 8,000 characters — download PDF for full document]